Unravelling Stent
| Reference number | |
| Coordinator | INKUBATORN I BORÅS AB |
| Funding from Vinnova | SEK 2 000 000 |
| Project duration | December 2013 - January 2016 |
| Status | Completed |
Purpose and goal
The goals with the project have been to prepare the first knitted and removable stent for human use and establish a business strategy. A variety of stents, material and knitting patterns have been tested and an ideal version is identified. A production unit is under establishment. The first human deployment is planned to 2017 and no hindrances remain to reach the goal. The business strategy will be to produce stents for one identified indication and to develop variants for other indications to be out licensed
Results and expected effects
The stent has been tested in repeated acute and chronic experiments in sheep and porcine models. The stent gives less restenosis in the vasculature. The deployment and removal works ideally in the airways. The CE marking is ongoing, including demands from FDA. A patent strategy is present. All needed partners to reach the market are defined. The project has interest from national and international investors and been in international media. A new important Swedish industry is expected to be established
Approach and implementation
A number of activities have been executed in parallel. These include; Product development, Mechanical and animal tests, CE-marking, Patent strategy, Market analysis, establishment of partners and production. The concerted actions have contributed to each other since they are all interrelated. The bottom line being that the project has reached far in spite of a low budget and a short time. More employees had been ideal but the content has been partly covered by student projects as a compensation for minimal labor